First Trimester Screening
First Trimester Ultrasound

First Trimester Screening is a test for Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome) and Trisomy 13 (Patau Syndrome). The test uses software by license from the Fetal Medicine Foundation. It uses a combination of background factors (predominantly age), ultrasound and biochemistry to give the pregnant woman a risk for the conditions listed above.  If biochemistry is available, the results are given immediately after the ultrasound, and appropriate counselling will be undertaken.  Each sonographer is subject to regular audit of their performance in order to maintain standards.  The audit is operated by RANZCOG.

For Trisomy 21, a risk of 1:300 or more is considered “high risk”. For Trisomy 13 and 18, a risk of 1:150 is considered “high risk”.

It is important to remember that First Trimester Screening is a test, not a diagnostic test. This is merely a guide as to whether further testing is warranted. This will be dependent on many factors, including the actual risk (eg 1:2 vs 1:299) and patient factors. Our doctors and trained sonographers will provide individualised counselling to help with the decision making process once a risk has been given, as every woman has different circumstances.

 Nuchal translucency measurement

Nuchal translucency is the term used to describe the appearance of a fluid-filled space at the back of a baby’s neck that can be seen using an ultrasound early in pregnancy.  The depth of the space at the back of the baby’s neck can be measured using ultrasound. This should be thin at this stage of pregnancy. The greater the depth of fluid, the more there is a  chance that the baby has a problem with his or her chromosomes, or some other structural abnormality.

Frequently asked questions regarding First Trimester Screening – please click here

Coronavirus (COVID-19) Health Alert

As Medical Imaging is considered an essential service, we are opened this week. But as guided by WA Health, all patients and staff are required to wear a mask whilst in the practice. Patients will be scanned alone with no accompanying person; and provided access to multiple images. All gynaecological procedures will be cancelled for now.

Please reschedule your appointment, and DO NOT ENTER our facilities, if you:

Have returned from interstate or overseas travel in the last 14 days; OR
Have been in contact with someone who has returned from interstate or overseas travel; OR
Have been in contact with someone who has a confirmed case of Coronavirus COVID-19; OR
Have a fever, cough, runny nose, sore throat, difficulty breathing, fatigue, or any cold/flu like symptoms.

If you fit this criteria, please self-isolate at home until the 15th day following travel or contact, even if you are feeling well. If you are showing respiratory or flu-like symptoms, telephone your doctor or hospital Emergency Department before presenting yourself. If you are experiencing severe symptoms, call '000' and advise the operator you are in self quarantine because of COVID-19 risk.

Western Ultrasound for Women encourages all to download and activate the SafeWA app to improve contact tracing.

Western Ultrasound is committed to the risk mitigation of Coronavirus COVID-19 as one of our priorities for patient safety and quality of care.

Due to the COVID-19 pandemic there may be changes to regular operating hours. We apologise in advance for any inconvenience arising from measures we're taking for the safety of staff and patients.

COVID-19 Health Information Hotline: 1800 020 080 | Department of Health Health Warnings

Updated 1 February 2021